Flow Traders U.S.’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Flow Traders U.S.’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,355	Closed	-$880K	–	1113
2025 Q4	$880K	Sell	19,355 -26,603	-58%	-$1.18M	0.03%	424
2025 Q3	$1.78M	Sell	45,958 -13,723	-23%	-$497K	0.07%	278
2025 Q2	$2.01M	Buy	59,681 +20,515	+52%	+$650K	0.07%	245
2025 Q1	$1.25M	Buy	39,166 +3,570	+10%	+$135K	0.05%	333
2024 Q4	$1.38M	Buy	35,596 +14,806	+71%	+$622K	0.06%	293
2024 Q3	$936K	Buy	+20,790	New	+$929K	0.05%	392
2021 Q3	–	Sell	-10,579	Closed	-$1.05M	–	1049
2021 Q2	$1.05M	Buy	10,579 +5,286	+100%	+$469K	0.05%	392
2021 Q1	$476K	Sell	5,293 -52	-1%	-$5.13K	0.03%	508
2020 Q4	$507K	Buy	+5,345	New	+$447K	0.03%	391

Other funds holding GNOM

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return